In 2021, the Chinese pharmaceutical companies invested between 1.27 and 12.63 percent of their sales revenue in research and development. That year, Livzon Pharmaceutical Group spent around 1.5 billion yuan on R&D, accounting for 12.63 percent of its sales revenue.
Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Pharmaceuticals Holding. (March 30, 2023). Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. "Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022." Chart. March 30, 2023. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. (2023). Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022. Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding. "Share of Research and Development in Sales Revenue of Selected Pharmaceutical Companies in China in 2021 and 2022." Statista, Statista Inc., 30 Mar 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/
Shanghai Pharmaceuticals Holding, Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/ (last visited September 20, 2024)
Share of research and development in sales revenue of selected pharmaceutical companies in China in 2021 and 2022 [Graph], Shanghai Pharmaceuticals Holding, March 30, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1076199/china-pharmaceutical-companies-research-and-development-sales-revenue-share/